-
October 3, 2008
Diabetes not linked with prostate cancer death
NEW YORK (Reuters Health) - Obesity, rather than diabetes, increases the risk that men being treated for locally advanced prostate cancer will die from the cancer, researchers report.
-
September 30, 2008
Return to breastfeeding urged amid China scandal
HONG KONG (Reuters) - China's contaminated milk products scandal, which have landed thousands of children in hospital in China this month with kidney illnesses, has reignited calls from medical experts for a return to breastfeeding.
-
September 24, 2008
Prostate cancer therapy linked to falls
NEW YORK (Reuters Health) - Older men with prostate cancer who are on long-term hormone therapy often become weaker physically, leading to an increased risk of falls and injury, researchers report.
-
September 24, 2008
Weight may influence how prostate cancer is treated
NEW YORK (Reuters Health) - Obese patients with prostate cancer appear to be more likely to receive non-surgical treatments than their normal-weight counterparts, new research shows.
-
September 23, 2008
Prostate cancer hormone therapy may raise mortality
NEW YORK (Reuters Health) - In elderly men with early-stage prostate cancer, receiving hormone therapy is associated with an increase in all-cause mortality, according to a study reported Tuesday at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting underway in Boston.
-
September 19, 2008
Barbershops become urban community health centers
TORONTO (Reuters) - African-Americans living in communities in the shadows of the University of Pittsburgh's buildings are getting sick and dying sooner than their white counterparts of preventable diseases -- and Dr. Stephen Thomas wants to change it.
-
September 16, 2008
Healthy lifestyle raises beneficial enzyme: study
WASHINGTON (Reuters) - Sweeping lifestyle changes including a better diet and more exercise can raise the body's levels of an enzyme closely involved in controlling the aging process, U.S. researchers reported on Monday.
-
September 10, 2008
McCain and Obama on same side in US war on cancer
NORFOLK, Virginia (Reuters Life!) - If there is one war John McCain and Barack Obama agree on, it's the one against cancer.
-
September 9, 2008
Height linked with aggressive prostate cancer
NEW YORK (Reuters Health) - Adult height, which can be an indicator of early life environmental exposures, is positively associated with prostate cancer, particularly aggressive disease, British investigators report in the current issue of the journal Cancer Epidemiology, Biomarkers and Prevention.
-
September 8, 2008
Pain relievers may complicate prostate screening
WASHINGTON (Reuters) - Taking a popular class of pain relievers that include aspirin and ibuprofen lowers the levels of a protein in a man's blood that doctors use to screen for prostate cancer, U.S. researchers said on Monday.
-
September 3, 2008
Prostate irradiation raises risk of colon cancer
NEW YORK (Reuters Health) - Data from the Geneva Cancer Registry show an increased long-term risk of colon cancer in men who have undergone external radiation therapy for prostate cancer.
-
September 3, 2008
High blood calcium tied to lethal prostate cancer
WASHINGTON (Reuters) - Men with elevated levels of calcium in their blood may have a much higher risk of getting fatal prostate cancer, U.S. researchers said on Wednesday.
-
August 27, 2008
Cell Genesys says higher deaths gag trial
BANGALORE (Reuters) - Cell Genesys Inc said it stopped a late-stage trial of its prostate cancer therapy, GVAX, after 20 more deaths were reported in patients on the drug versus those on a dummy treatment, and its shares crashed more than 75 percent to an all-time low.
-
August 22, 2008
Prostate cancer risk increased in obese men: study
NEW YORK (Reuters Health) - Use of cholesterol-lowering statin drugs, especially long-term use, appears to raise the risk of prostate cancer among obese men, according to findings of a new study.
-
August 13, 2008
Study sees benefit in prostate cancer surgery
WASHINGTON (Reuters) - Men with early prostate cancer who have their prostate glands surgically removed are less likely to die from the disease than those who take a wait-and-see approach, researchers said on Tuesday.
-
August 11, 2008
One in five young men checked for prostate cancer
NEW YORK (Reuters Health) - New research suggests that roughly one in five American men in their 40s has had a blood test to screen for prostate cancer within the last year. However, screening rates in black men are still considered suboptimal, the investigators say.
-
August 8, 2008
Estrogen patch shows promise for prostate cancer
NEW YORK (Reuters Health) - A patch that delivers estrogen through the skin may prove useful in treating advanced cases of prostate cancer, preliminary research suggests.
-
August 8, 2008
Prostate cancer prognosis worse in obese men
NEW YORK (Reuters Health) - Prostate cancer diagnosis tends to be delayed and surgical treatment more difficult in obese men than in lean men, according to two studies published Friday.
-
August 8, 2008
UK newspaper apologises for royal "cancer" story
LONDON (Reuters Life!) - London's Evening Standard newspaper was forced to apologise on Friday after falsely reporting that Prince Philip was suffering from prostate cancer.
-
August 6, 2008
Racial differences again seen in prostate cancer
NEW YORK (Reuters Health) - Black men with prostate cancer, compared with their White counterparts, have a poorer prognosis that is not fully explained by other "co-morbid" illnesses, or by different screening rates or access to healthcare, researchers from the UK report.
-
August 5, 2008
Delay in body growth linked to prostate cancer
NEW YORK (Reuters Health) - Boys who reach their adult body size in their early 20s may be more prone to prostate cancer later in life than their peers who achieve their adult size during adolescence, Italian researchers report.
-
August 4, 2008
Prostate cancer checks not advised for men over 74
NEW YORK (Reuters Health) - In an update to its 2002 prostate cancer screening guidelines, the US Preventive Services Task Force is now recommending that screening not be performed for men 75 years of age or older, due to a lack of overall benefit.
-
August 4, 2008
Erectile dysfunction may be "normal" with age
NEW YORK (Reuters Health) - Erectile dysfunction may be a feature of normal aging in men, while urinary or bowel function doesn't necessarily decline with age, according to a Dutch study.
-
July 28, 2008
Prostate cancer therapy may impair cognition
NEW YORK (Reuters Health) - Up to 69 percent of men who receive hormone deprivation therapy for prostate cancer will experience some degree of cognitive impairment, such as in the ability to concentrate, a review of published data suggests.
-
July 22, 2008
New drug helps shrink prostate tumors: study
LONDON (Reuters) - A once-a-day pill significantly shrank tumors in men with advanced prostate cancer who had not responded to other treatments, researchers said on Tuesday.
-
July 18, 2008
Bone drug has benefits in cancer patients
NEW YORK (Reuters Health) - The bone-strengthening drug zoledronic acid not only reduces fracture risk in patients with cancer that has spread to the bones, it also improves overall survival, according to the results of a retrospective analysis of three large studies.
-
July 18, 2008
Racial disparity seen in prostate cancer treatment
NEW YORK (Reuters Health) - Black men with early prostate cancer may be less likely to receive aggressive treatment than their white counterparts, a small study has found.
-
July 14, 2008
Drug prevents bone loss in prostate cancer - Amgen
CHICAGO (Reuters) - Amgen Inc on Monday said that a trial of its experimental drug denosumab showed that it can prevent osteoporosis in men being treated with prostate cancer drugs that can cause bone loss.
-
July 11, 2008
Virus helps flush cancer cells out of hiding
CHICAGO (Reuters Life!) - A genetically engineered version of the cold virus helped flush dangerous prostate cancer cells out of hiding in mice, making them easier to see on imaging equipment, U.S. researchers said on Friday.
-
July 11, 2008
High CRP predicts poor outcome in prostate cancer
NEW YORK (Reuters Health) - High blood levels of a protein linked to inflammation known as CRP is associated with poor survival and a lower probability of response to treatment in men with "hormone-independent" prostate cancer.
-
July 11, 2008
ED from prostate cancer hormone therapy treatable
NEW YORK (Reuters Health) - A new study shows that a substantial minority of men receiving so-called androgen deprivation therapy, or ADT, for prostate cancer experience erectile dysfunction (ED). However, many respond well to ED therapy, doctors from Memphis have found.
-
July 8, 2008
Little benefit to common prostate cancer treatment
NEW YORK (Reuters Health) - In elderly men with localized or "organ-confined" prostate cancer, a therapy that involves depriving the prostate gland the male hormone androgen, which is known to promote prostate cancer growth, does not appear to improve survival, compared to a conservative "wait and see" management strategy, a study shows.
-
July 2, 2008
High fat diet may abet prostate cancer progression
NEW YORK (Reuters Health) - Diets high in saturated fat may increase the risk of prostate cancer progression, researchers from the University of Texas M. D. Anderson Cancer Center in Houston report.
-
July 2, 2008
Study shows how broccoli fights cancer
LONDON (Reuters) - Just a few more portions of broccoli each week may protect men from prostate cancer, British researchers reported on Wednesday.
-
June 30, 2008
Accidental fungus leads to promising cancer drug
WASHINGTON (Reuters) - A drug developed using nanotechnology and a fungus that contaminated a lab experiment may be broadly effective against a range of cancers, U.S. researchers reported on Sunday.
-
June 27, 2008
Obesity may interfere with prostate cancer screen
NEW YORK (Reuters Health) - The test commonly used to screen men for prostate cancer may be more likely to miss tumors in obese men, a new study suggests.
-
June 26, 2008
MRI combo spots prostate cancer treatment failure
NEW YORK (Reuters Health) - Two imaging modalities used in combination -- dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging (DWI)-MRI -- can accurately spot residual or recurrent prostate cancer in patients treated with a fairly new treatment called high-intensity focused ultrasonic ablation, a new study shows.
-
June 17, 2008
Radiation may help after prostate cancer setback
NEW YORK (Reuters Health) - Men whose prostate cancer recurs after they have undergone surgical removal of the prostate may benefit from early radiation therapy, according to study findings reported in this week's Journal of the American Medical Association.
-
June 17, 2008
Healthy lifestyle triggers genetic changes: study
WASHINGTON (Reuters) - Comprehensive lifestyle changes, including a better diet and more exercise, can lead not only to a better physique but also to swift and dramatic changes at the genetic level, U.S. researchers said on Monday.
-
June 12, 2008
Proscar lowers prostate cancer risk in all men
NEW YORK (Reuters Health) - Finasteride (Proscar) reduces the risk of prostate cancer in all men, regardless of their risk level for the disease, new research shows.
-
June 12, 2008
Overactive bladder affects many aspects of life
NEW YORK (Reuters Health) - An overactive bladder has a considerable effect on the quality of life, work productivity, sexuality and the emotional well-being of men and women, U.S. and European researchers report in the journal BJU International.
-
June 11, 2008
Radiation, chemo costs drive cancer spending in US
WASHINGTON (Reuters Life!) - The cost of treating cancer has soared in the United States as more chemotherapy and radiation treatments become available to more patients, researchers reported on Tuesday.
-
June 9, 2008
Dehydrated tomatoes may fight prostate tumors
NEW YORK (Reuters Health) - A compound found in dehydrated tomatoes may help quash prostate cancer tumors, new animal research suggests.
-
June 3, 2008
Drug avoids radiation for early testicular cancer
NEW YORK (Reuters Health) - In men who are diagnosed with earl-stage testicular cancer, a single dose of the chemotherapy drug carboplatin is as effective radiation therapy and is much less toxic, according to study findings presented at the American Society of Clinical Oncology annual meeting in Chicago.
-
May 30, 2008
Lung cancer patients fight stigma
WASHINGTON (Reuters Life!) - "I'm sorry. You don't have breast cancer," the oncologist told Charmaine Atkenson.
-
May 27, 2008
Gum disease may raise cancer risk, study finds
CHICAGO (Reuters) - Gum disease may increase the risk of developing cancer, researchers said on Tuesday.
-
May 27, 2008
Vitamin D linked to aggressive prostate cancer
NEW YORK (Reuters Health) - Contrary to findings from some earlier studies, new research suggests that high vitamin D levels do not decrease the risk of prostate cancer. In fact, high vitamin D seems to be linked to an increased risk of aggressive disease -- although the researchers emphasize that these findings might have occurred by chance.
-
May 21, 2008
Cancer risk soars in HIV-infected people: study
WASHINGTON (Reuters) - People with HIV have a much higher risk for many cancers, including anal cancer, but a lower risk for prostate cancer, researchers said on Tuesday.
-
May 20, 2008
New analysis boosts drug's prostate cancer value
WASHINGTON (Reuters) - A new analysis of data from a key prostate cancer study has strengthened the view that a drug that is now sold as a generic may be a valuable weapon to prevent prostate cancer, researchers said on Monday.
-
May 15, 2008
Rapid prostate cancer test does not ease anxiety
NEW YORK (Reuters Health) - The stress and anxiety associated with receiving results of a prostate-specific antigen (PSA) test for prostate cancer is not relieved by using rapid PSA tests, but men still prefer to have their results quickly, results of a study indicate.